• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Chemotaxigenesis and activation of the alternative complement pathway by encapsulated and non-encapsulated Cryptococcus neoformans.被包囊和未被包囊的新型隐球菌的趋化性发生及替代补体途径的激活
Infect Immun. 1979 Nov;26(2):435-40. doi: 10.1128/iai.26.2.435-440.1979.
2
Activation and binding of opsonic fragments of C3 on encapsulated Cryptococcus neoformans by using an alternative complement pathway reconstituted from six isolated proteins.通过使用由六种分离蛋白重构的替代补体途径,C3调理素片段在荚膜新生隐球菌上的激活与结合。
Infect Immun. 1989 Jul;57(7):1922-7. doi: 10.1128/iai.57.7.1922-1927.1989.
3
Anti-chemotactic activity of capsular polysaccharide of Cryptococcus neoformans in vitro.新型隐球菌荚膜多糖的体外抗趋化活性
Microbiol Immunol. 1997;41(9):657-64. doi: 10.1111/j.1348-0421.1997.tb01908.x.
4
Role of serum factors in the phagocytosis of weakly or heavily encapsulated Cryptococcus neoformans strains by guinea pig peripheral blood leukocytes.血清因子在豚鼠外周血白细胞对轻度或重度荚膜化新型隐球菌菌株的吞噬作用中的作用。
Microbiol Immunol. 1984;28(1):51-61. doi: 10.1111/j.1348-0421.1984.tb02946.x.
5
Early events in initiation of alternative complement pathway activation by the capsule of Cryptococcus neoformans.新型隐球菌荚膜启动替代补体途径激活的早期事件。
Infect Immun. 1991 Sep;59(9):3101-10. doi: 10.1128/iai.59.9.3101-3110.1991.
6
Role of the capsule in phagocytosis of Cryptococcus neoformans.荚膜在新型隐球菌吞噬作用中的作用。
Rev Infect Dis. 1988 Jul-Aug;10 Suppl 2:S436-9. doi: 10.1093/cid/10.supplement_2.s436.
7
Binding of cryptococcal polysaccharide to Cryptococcus neoformans.隐球菌多糖与新型隐球菌的结合。
Infect Immun. 1984 Mar;43(3):879-86. doi: 10.1128/iai.43.3.879-886.1984.
8
Strain variation in phagocytosis of Cryptococcus neoformans: dissociation of susceptibility to phagocytosis from activation and binding of opsonic fragments of C3.新型隐球菌吞噬作用中的菌株变异:吞噬易感性与C3调理片段的激活及结合的解离
Infect Immun. 1988 Nov;56(11):2794-800. doi: 10.1128/iai.56.11.2794-2800.1988.
9
Localization on encapsulated Cryptococcus neoformans of serum components opsonic for phagocytosis by macrophages and neutrophils.血清成分对巨噬细胞和中性粒细胞吞噬新生隐球菌的调理作用的定位。
Infect Immun. 1984 Feb;43(2):574-9. doi: 10.1128/iai.43.2.574-579.1984.
10
Activation of the complement system by the capsule of Cryptococcus neoformans.新型隐球菌荚膜激活补体系统。
Curr Top Med Mycol. 1993;5:1-26.

引用本文的文献

1
Real-Time Imaging of Interactions of Neutrophils with Cryptococcus neoformans Demonstrates a Crucial Role of Complement C5a-C5aR Signaling.中性粒细胞与新型隐球菌相互作用的实时成像显示补体C5a - C5aR信号传导的关键作用。
Infect Immun. 2015 Oct 26;84(1):216-29. doi: 10.1128/IAI.01197-15. Print 2016 Jan.
2
The Vi capsular polysaccharide enables Salmonella enterica serovar typhi to evade microbe-guided neutrophil chemotaxis.Vi 荚膜多糖使伤寒沙门氏菌能够逃避微生物引导的中性粒细胞趋化作用。
PLoS Pathog. 2014 Aug 7;10(8):e1004306. doi: 10.1371/journal.ppat.1004306. eCollection 2014 Aug.
3
In vitro C3 deposition on Cryptococcus capsule occurs via multiple complement activation pathways.在体外,C3 在隐球菌荚膜上的沉积是通过多种补体激活途径发生的。
Mol Immunol. 2011 Sep;48(15-16):2009-18. doi: 10.1016/j.molimm.2011.06.215. Epub 2011 Jul 1.
4
Cryptococcal interactions with the host immune system.新型隐球菌与宿主免疫系统的相互作用。
Eukaryot Cell. 2010 Jun;9(6):835-46. doi: 10.1128/EC.00039-10. Epub 2010 Apr 9.
5
The capsule of the fungal pathogen Cryptococcus neoformans.新型隐球菌这种真菌病原体的荚膜。
Adv Appl Microbiol. 2009;68:133-216. doi: 10.1016/S0065-2164(09)01204-0.
6
Role of complement in protection against Cryptococcus gattii infection.补体在抵御加氏隐球菌感染中的作用。
Infect Immun. 2009 Mar;77(3):1061-70. doi: 10.1128/IAI.01119-08. Epub 2008 Dec 29.
7
Of mice and men, revisited: new insights into an ancient molecule from studies of complement activation by Cryptococcus neoformans.《人鼠之间》再探讨:从新型隐球菌补体激活研究中获得的关于一种古老分子的新见解
Infect Immun. 2006 Jun;74(6):3079-84. doi: 10.1128/IAI.00431-06.
8
Modulation of C5aR expression on human neutrophils by encapsulated and acapsular Cryptococcus neoformans.被包囊和无包囊的新型隐球菌对人中性粒细胞上C5aR表达的调节作用
Infect Immun. 2002 Jul;70(7):3363-70. doi: 10.1128/IAI.70.7.3363-3370.2002.
9
Interdependency of interleukin-10 and interleukin-12 in regulation of T-cell differentiation and effector function of monocytes in response to stimulation with Cryptococcus neoformans.白细胞介素-10与白细胞介素-12在调节T细胞分化及单核细胞对新型隐球菌刺激的效应功能中的相互依赖性。
Infect Immun. 2001 Oct;69(10):6064-73. doi: 10.1128/IAI.69.10.6064-6073.2001.
10
Susceptibilities of Cryptococcus neoformans strains to platelet binding in vivo and to the fungicidal activity of thrombin-induced platelet microbicidal proteins in vitro.新型隐球菌菌株在体内对血小板结合以及在体外对凝血酶诱导的血小板杀菌蛋白的杀真菌活性的敏感性。
Infect Immun. 2001 Feb;69(2):1221-5. doi: 10.1128/IAI.69.2.1221-1225.2001.

本文引用的文献

1
Nonencapsulated Variant of Cryptococcus neoformans I. Virulence Studies and Characterization of Soluble Polysaccharide.新型隐球菌非包被变异株 I. 毒力研究及可溶性多糖的特性。
Infect Immun. 1971 Feb;3(2):287-94. doi: 10.1128/iai.3.2.287-294.1971.
2
Tissue changes and tissue diagnosis in cryptococcosis; a study of 26 cases.隐球菌病的组织变化与组织诊断;26例研究
Am J Clin Pathol. 1955 Jan;25(1):14-24. doi: 10.1093/ajcp/25.1.14.
3
Natural host resistance to infection with Cryptococcus neoformans. I. The effect of the properdin system on the experimental disease.宿主对新型隐球菌感染的天然抵抗力。I. 备解素系统对实验性疾病的影响。
J Infect Dis. 1961 Sep-Oct;109:147-53. doi: 10.1093/infdis/109.2.147.
4
Prognostic factors in cryptococcal meningitis. A study in 111 cases.隐球菌性脑膜炎的预后因素。111例病例研究。
Ann Intern Med. 1974 Feb;80(2):176-81. doi: 10.7326/0003-4819-80-2-176.
5
The role of the classical and alternate complement pathways in host defenses against Cryptococcus neoformans infection.经典补体途径和替代补体途径在宿主抵御新型隐球菌感染中的作用。
J Immunol. 1974 Jun;112(6):2260-70.
6
Histologic response to capsule-deficient Cryptococcus neoformans.对缺乏荚膜的新型隐球菌的组织学反应。
Arch Pathol. 1973 Dec;96(6):383-7.
7
Candida albicans and the chemotaxis of polymorphonuclear neutrophils.白色念珠菌与多形核中性粒细胞的趋化作用
Sabouraudia. 1973 Nov;11(3):210-21.
8
In vitro phagocytosis and intracellular fate of variously encapsulated strains of Cryptococcus neoformans.新型隐球菌不同包囊菌株的体外吞噬作用及细胞内命运
Infect Immun. 1972 Apr;5(4):491-8. doi: 10.1128/iai.5.4.491-498.1972.
9
The C3-activator system: an alternate pathway of complement activation.C3激活剂系统:补体激活的替代途径。
J Exp Med. 1971 Sep 1;134(3 Pt 2):90s-108s.
10
Haemolytic diffusion plate assays for factors B and D of the alternative pathway of complement activation.补体激活替代途径中B因子和D因子的溶血扩散平板试验。
Immunochemistry. 1976 Apr;13(4):317-24. doi: 10.1016/0019-2791(76)90341-4.

被包囊和未被包囊的新型隐球菌的趋化性发生及替代补体途径的激活

Chemotaxigenesis and activation of the alternative complement pathway by encapsulated and non-encapsulated Cryptococcus neoformans.

作者信息

Laxalt K A, Kozel T R

出版信息

Infect Immun. 1979 Nov;26(2):435-40. doi: 10.1128/iai.26.2.435-440.1979.

DOI:10.1128/iai.26.2.435-440.1979
PMID:397927
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC414633/
Abstract

In the presence of serum, whole cells of encapsulated and non-encapsulated Cryptococcus neoformans generated a chemotactic response by neutrophils. Heat inactivation of serum ablated all chemotactic activity. Cryptococcal polysaccharide was not chemotaxigenic. Assays for alternative complement pathway activation such as depletion of alternative complement pathway factor B or electrophoretic conversion of factor B closely paralleled chemotaxis assays. Cells of encapsulated and non-encapsulated C. neoformans activated the alternative complement pathway, whereas cryptococcal polysaccharide was inactive. Failure of the capsular material to activate the alternative pathway was not due to serotype specificity because polysaccharide of several serotypes failed to achieve activation. The results suggest that chemotaxigenesis and alternative complement pathway activation are functions of the yeast cell wall. The results support our proposal that the cryptococcal capsul does not prevent potential opsonins from reaching binding and activation sites at the yeast cell wall or the release of biologically active soluble cleavage products into the surrounding medium; however, cell wall-bound cleavage products remain bound to the cell wall beneath the capsule. Therefore, they are unable to participate as opsonins in phagocytosis.

摘要

在有血清存在的情况下,被包裹和未被包裹的新型隐球菌全细胞会引发中性粒细胞的趋化反应。血清经热灭活后,所有趋化活性均消失。隐球菌多糖没有趋化作用。对替代补体途径激活的检测,如替代补体途径因子B的消耗或因子B的电泳转化,与趋化性检测密切相关。被包裹和未被包裹的新型隐球菌细胞激活了替代补体途径,而隐球菌多糖则无活性。荚膜物质未能激活替代途径并非由于血清型特异性,因为几种血清型的多糖都未能实现激活。结果表明,趋化作用和替代补体途径激活是酵母细胞壁的功能。这些结果支持了我们的提议,即隐球菌荚膜并不能阻止潜在的调理素到达酵母细胞壁上的结合和激活位点,也不能阻止生物活性可溶性裂解产物释放到周围介质中;然而,细胞壁结合的裂解产物仍结合在荚膜下方的细胞壁上。因此,它们无法作为调理素参与吞噬作用。